Invention Grant
- Patent Title: Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
-
Application No.: US14169584Application Date: 2014-01-31
-
Publication No.: US09856234B2Publication Date: 2018-01-02
- Inventor: Sean Colm Turner , Margaretha Henrica Maria Bakker , Kent D. Stewart
- Applicant: ABBVIE INC. , ABBVIE DEUTSCHLAND GMBH & CO. KG
- Applicant Address: DE Wiesbaden US IL North Chicago
- Assignee: ABBVIE DEUTSCHLAND GMBH & CO. KG,ABBVIE INC.
- Current Assignee: ABBVIE DEUTSCHLAND GMBH & CO. KG,ABBVIE INC.
- Current Assignee Address: DE Wiesbaden US IL North Chicago
- Agency: Neal, Gerber & Eisenberg LLP
- Priority: EP06022094 20061021
- Main IPC: C07D345/00
- IPC: C07D345/00 ; C07D517/00 ; C07D401/12 ; C07D413/14 ; C07D471/04 ; C07D241/20
Abstract:
The present invention relates to a heterocyclic compound of the general formula (I) and their use and preparation, methods of making the compounds, compositions containing at least one of said compounds, and methods of treatment using at least one compound. In particular, compounds of the general formula (I) are useful for inhibiting glycogen synthase kinase 3 (GSK-3).
Public/Granted literature
- US20140148458A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE 3 INHIBITORS Public/Granted day:2014-05-29
Information query
